Drug Pipeline

LY4256984 Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
3
Active Studies
1
Recruiting
1
Top Sponsors
Active Studies by Phase
Phase 1
3
Active Trials
NCT IDTitleConditionStatus
Phase 1
NCT07100119 A Study of LY4256984 in Participants With Sporadic Amyotrophic Lateral Sclerosis ALS (Amyotrophic Lateral Sclerosis) Recruiting
NCT07571200 A Master Protocol (OLMP): A Study of LY4256984 in Participants With Amyotrophic Lateral… Amyotrophic Lateral Sclerosis Not Yet Recruiting
NCT07571174 A Substudy of LY4256984 in Participants With Sporadic Amyotrophic Lateral Sclerosis Amyotrophic Lateral Sclerosis Not Yet Recruiting
Sponsors Running LY4256984 Trials
Eli Lilly and Company (3)
Disease Areas
ALS (3)
Get alerts when LY4256984 trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free